TikTok creator's GLP-1 blood pressure claims fact-checked

What does this video actually claim?

@loracroftcheck says she's been off blood pressure medications and moved from an unhealthy to healthy BMI after 21 weeks on a GLP-1 medication through Mochi Health. She's promoting eligibility for the telehealth service while sharing her personal transformation story.

The creator doesn't specify which GLP-1 medication she's taking, though Mochi Health typically prescribes semaglutide or tirzepatide. Her claims focus on two major health improvements: eliminating blood pressure medication and achieving a healthy BMI range.

Do GLP-1 medications actually improve blood pressure?

Yes, and the data is solid. The STEP 1 trial (Wilding et al., NEJM, 2021) found semaglutide 2.4mg reduced systolic blood pressure by 6.2 mmHg compared to placebo at 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed tirzepatide reduced systolic BP by 7.4-10.6 mmHg depending on dose.

These aren't small changes. A 5 mmHg reduction in systolic blood pressure typically reduces cardiovascular risk by about 10%. Weight loss of 15-20% often allows patients to reduce or eliminate blood pressure medications under medical supervision.

The timeline makes sense too. Most patients see meaningful blood pressure improvements within 12-16 weeks of starting GLP-1 therapy as weight loss progresses.

What about the BMI claims?

Moving from an unhealthy to healthy BMI in 21 weeks is achievable with GLP-1 medications, depending on starting weight. The STEP 1 trial showed 14.9% average weight loss at 68 weeks with semaglutide, while SURMOUNT-1 demonstrated 15-22.5% weight loss with tirzepatide.

Someone starting with a BMI of 32 (class 1 obesity) would need about 15% weight loss to reach a BMI under 25. That's absolutely possible in 21 weeks with these medications.

However, the creator doesn't share specific numbers. Without knowing her starting BMI or total weight lost, we can't verify her exact claims.

What's missing from this promotion?

The video glosses over side effects, which is misleading. Up to 44% of patients experience nausea on semaglutide 2.4mg, and 12% discontinue treatment due to gastrointestinal issues according to STEP 1 data.

She also doesn't mention that stopping blood pressure medication requires medical supervision. You can't just quit based on feeling better. Blood pressure needs monitoring and gradual medication tapering.

The promotional aspect is concerning too. While she discloses her connection to Mochi Health, the video reads more like an advertisement than balanced health information.

What should you actually know?

GLP-1 medications can genuinely improve blood pressure and BMI, but individual results vary widely. Not everyone achieves healthy BMI ranges, and not everyone can discontinue blood pressure medications.

The STEP 1 trial showed 32% of patients achieved less than 5% weight loss with semaglutide. About 15% discontinued due to side effects. These medications work well for many people but aren't magic bullets.

If you're considering GLP-1 therapy, discuss realistic expectations with your doctor. Blood pressure medication changes require medical oversight, and weight loss timelines vary significantly between individuals.